Search details
1.
Cardio-renal-metabolic disease in primary care setting.
Diabetes Metab Res Rev
; 40(3): e3755, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38115715
2.
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared with Originator Insulin Glargine (Lantus®) in Patients with Type 1 Diabetes after 26 Weeks Treatment.
Endocr Pract
; 2024 Jun 12.
Article
in English
| MEDLINE | ID: mdl-38876181
3.
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization.
Circulation
; 142(12): 1205-1218, 2020 09 22.
Article
in English
| MEDLINE | ID: mdl-32955939
4.
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
Endocr Pract
; 27(6): 505-537, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34116789
5.
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Endocr Pract
; 26(10): 1196-1224, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-33471721
6.
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study.
Diabetologia
; 62(6): 948-958, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30953107
7.
Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes.
Diabetes Obes Metab
; 21(4): 883-892, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30499237
8.
EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES.
Endocr Pract
; 25(2): 144-155, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30383495
9.
Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes.
Diabetes Obes Metab
; 20(12): 2821-2829, 2018 12.
Article
in English
| MEDLINE | ID: mdl-29974618
10.
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT.
Endocr Pract
; 24(11): 995-1011, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30763128
11.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
Endocr Pract
; 24(3): 302-308, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-29547046
12.
DCRM Multispecialty Recommendations in Patients With Heart Failure.
J Card Fail
; 28(11): 1642-1645, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35973620
13.
Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II.
Diabetes Obes Metab
; 19(7): 989-996, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28206704
14.
TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Endocr Pract
; 23(1): 100-112, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27819772
15.
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.
Endocr Pract
; 23(11): 1345-1349, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-29190135
16.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.
Endocr Pract
; 23(12): 1472-1478, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-29320641
17.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Endocr Pract
; 23(Suppl 2): 1-87, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28437620
18.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
Endocr Pract
; 23(4): 479-497, 2017 Apr 02.
Article
in English
| MEDLINE | ID: mdl-28156151
19.
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
JAMA
; 318(1): 45-56, 2017 Jul 04.
Article
in English
| MEDLINE | ID: mdl-28672317
20.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.
Endocr Pract
; 22(2): 231-61, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26848630